annual SGA:
$267.50M+$34.90M(+15.00%)Summary
- As of today (June 22, 2025), IONS annual SGA is $267.50 million, with the most recent change of +$34.90 million (+15.00%) on December 31, 2024.
- During the last 3 years, IONS annual SGA has risen by +$96.60 million (+56.52%).
- IONS annual SGA is now -19.48% below its all-time high of $332.20 million, reached on December 31, 2020.
Performance
IONS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$76.30M-$11.80M(-13.39%)Summary
- As of today (June 22, 2025), IONS quarterly SGA is $76.30 million, with the most recent change of -$11.80 million (-13.39%) on March 31, 2025.
- Over the past year, IONS quarterly SGA has increased by +$23.70 million (+45.06%).
- IONS quarterly SGA is now -34.62% below its all-time high of $116.70 million, reached on December 31, 2020.
Performance
IONS quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$8.80B-$458.03M(-5.49%)Summary
- As of today (June 22, 2025), IONS TTM SGA is -$8.80 billion, with the most recent change of -$458.03 million (-5.49%) on March 31, 2025.
- Over the past year, IONS TTM SGA has dropped by -$9.04 billion (-3769.36%).
- IONS TTM SGA is now -122080.44% below its all-time high of -$7.20 million.
Performance
IONS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
IONS Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.0% | +45.1% | -3769.4% |
3 y3 years | +56.5% | +123.6% | -6046.9% |
5 y5 years | -6.7% | +1.7% | -3098.1% |
IONS Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +78.0% | -13.4% | +125.7% | -73.5% | at low |
5 y | 5-year | -19.5% | +78.0% | -34.6% | +153.5% | -167.4% | at low |
alltime | all time | -19.5% | >+9999.0% | -34.6% | +516.9% | <-9999.0% | at low |
IONS Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $76.30M(-13.4%) | $291.11M(+8.9%) |
Dec 2024 | $267.50M(+15.0%) | $88.10M(+43.0%) | $267.41M(+6.8%) |
Sep 2024 | - | $61.60M(-5.4%) | $250.31M(-3.2%) |
Jun 2024 | - | $65.11M(+23.8%) | $258.71M(+7.9%) |
Mar 2024 | - | $52.60M(-25.9%) | $239.74M(+3.0%) |
Dec 2023 | $232.60M(+54.8%) | $71.00M(+1.4%) | $232.66M(+11.0%) |
Sep 2023 | - | $70.00M(+51.7%) | $209.55M(+20.5%) |
Jun 2023 | - | $46.14M(+1.4%) | $173.95M(+7.6%) |
Mar 2023 | - | $45.52M(-5.0%) | $161.61M(+7.6%) |
Dec 2022 | $150.29M(-12.1%) | $47.90M(+39.2%) | $150.22M(+6.6%) |
Sep 2022 | - | $34.40M(+1.8%) | $140.93M(+3.1%) |
Jun 2022 | - | $33.80M(-1.0%) | $136.63M(-7.6%) |
Mar 2022 | - | $34.13M(-11.6%) | $147.93M(-13.4%) |
Dec 2021 | $170.90M(-48.6%) | $38.60M(+28.2%) | $170.90M(-31.4%) |
Sep 2021 | - | $30.10M(-33.3%) | $249.00M(-13.3%) |
Jun 2021 | - | $45.10M(-21.0%) | $287.30M(-8.6%) |
Mar 2021 | - | $57.10M(-51.1%) | $314.21M(-5.4%) |
Dec 2020 | $332.20M(+15.9%) | $116.70M(+70.6%) | $332.12M(+11.2%) |
Sep 2020 | - | $68.40M(-5.0%) | $298.69M(+2.9%) |
Jun 2020 | - | $72.02M(-4.0%) | $290.33M(-1.1%) |
Mar 2020 | - | $75.00M(-9.9%) | $293.42M(+2.4%) |
Dec 2019 | $286.64M(+17.2%) | $83.28M(+38.7%) | $286.64M(+6.4%) |
Sep 2019 | - | $60.04M(-20.1%) | $269.43M(-3.1%) |
Jun 2019 | - | $75.11M(+10.1%) | $278.10M(+3.3%) |
Mar 2019 | - | $68.22M(+3.3%) | $269.19M(+10.0%) |
Dec 2018 | $244.62M(+125.5%) | $66.06M(-3.9%) | $244.62M(+9.1%) |
Sep 2018 | - | $68.71M(+3.8%) | $224.27M(+23.0%) |
Jun 2018 | - | $66.20M(+51.6%) | $182.34M(+31.7%) |
Mar 2018 | - | $43.65M(-4.5%) | $138.46M(+27.6%) |
Dec 2017 | $108.49M(+123.2%) | $45.71M(+70.6%) | $108.49M(+34.2%) |
Sep 2017 | - | $26.79M(+20.0%) | $80.82M(+25.8%) |
Jun 2017 | - | $22.32M(+63.2%) | $64.22M(+24.1%) |
Mar 2017 | - | $13.68M(-24.2%) | $51.73M(+6.4%) |
Dec 2016 | $48.62M(+30.8%) | $18.04M(+77.1%) | $48.62M(+11.1%) |
Sep 2016 | - | $10.19M(+3.7%) | $43.76M(+3.4%) |
Jun 2016 | - | $9.82M(-7.0%) | $42.32M(+5.1%) |
Mar 2016 | - | $10.56M(-19.9%) | $40.27M(+8.3%) |
Dec 2015 | $37.17M(+84.6%) | $13.18M(+50.6%) | $37.17M(+20.6%) |
Sep 2015 | - | $8.75M(+12.6%) | $30.82M(+16.1%) |
Jun 2015 | - | $7.78M(+4.1%) | $26.54M(+14.3%) |
Mar 2015 | - | $7.47M(+9.4%) | $23.23M(+15.3%) |
Dec 2014 | $20.14M(+35.0%) | $6.83M(+52.7%) | $20.14M(+12.0%) |
Sep 2014 | - | $4.47M(+0.2%) | $17.99M(+6.1%) |
Jun 2014 | - | $4.46M(+1.9%) | $16.95M(+6.8%) |
Mar 2014 | - | $4.38M(-6.4%) | $15.88M(+6.4%) |
Dec 2013 | $14.92M(+19.2%) | $4.68M(+36.4%) | $14.92M(+10.7%) |
Sep 2013 | - | $3.43M(+1.2%) | $13.48M(+2.5%) |
Jun 2013 | - | $3.39M(-1.0%) | $13.14M(+1.4%) |
Mar 2013 | - | $3.42M(+5.8%) | $12.96M(+3.6%) |
Dec 2012 | $12.52M(-2.1%) | $3.23M(+4.5%) | $12.52M(-4.3%) |
Sep 2012 | - | $3.10M(-3.5%) | $13.08M(-0.1%) |
Jun 2012 | - | $3.21M(+7.8%) | $13.09M(+2.6%) |
Mar 2012 | - | $2.98M(-21.7%) | $12.76M(-0.3%) |
Dec 2011 | $12.79M(+9.6%) | $3.80M(+22.4%) | $12.79M(+7.2%) |
Sep 2011 | - | $3.10M(+8.0%) | $11.93M(+2.1%) |
Jun 2011 | - | $2.87M(-4.5%) | $11.68M(-1.5%) |
Mar 2011 | - | $3.01M(+2.2%) | $11.86M(+1.6%) |
Dec 2010 | $11.67M(-19.6%) | $2.94M(+3.2%) | $11.67M(-7.0%) |
Sep 2010 | - | $2.85M(-6.4%) | $12.55M(-3.7%) |
Jun 2010 | - | $3.05M(+8.2%) | $13.04M(-4.6%) |
Mar 2010 | - | $2.82M(-26.4%) | $13.66M(-5.9%) |
Dec 2009 | $14.52M(+5.1%) | $3.83M(+14.8%) | $14.52M(-3.7%) |
Sep 2009 | - | $3.33M(-9.2%) | $15.07M(+0.5%) |
Jun 2009 | - | $3.67M(-0.1%) | $15.00M(+2.3%) |
Mar 2009 | - | $3.68M(-16.1%) | $14.66M(+6.1%) |
Dec 2008 | $13.81M(+5.8%) | $4.38M(+34.3%) | $13.81M(+17.9%) |
Sep 2008 | - | $3.26M(-2.1%) | $11.72M(-8.0%) |
Jun 2008 | - | $3.33M(+17.8%) | $12.73M(+2.0%) |
Mar 2008 | - | $2.83M(+23.6%) | $12.49M(-4.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | $13.06M(+16.6%) | $2.29M(-46.5%) | $13.06M(-5.9%) |
Sep 2007 | - | $4.28M(+38.5%) | $13.87M(+11.7%) |
Jun 2007 | - | $3.09M(-9.2%) | $12.42M(+3.1%) |
Mar 2007 | - | $3.40M(+9.6%) | $12.04M(+7.5%) |
Dec 2006 | $11.20M(+42.0%) | $3.10M(+9.9%) | $11.20M(+3.4%) |
Sep 2006 | - | $2.82M(+4.2%) | $10.83M(+11.1%) |
Jun 2006 | - | $2.71M(+5.6%) | $9.74M(+8.9%) |
Mar 2006 | - | $2.57M(-6.0%) | $8.95M(+13.5%) |
Dec 2005 | $7.89M(-17.6%) | $2.73M(+57.0%) | $7.89M(-1.3%) |
Sep 2005 | - | $1.74M(-9.2%) | $7.99M(-2.1%) |
Jun 2005 | - | $1.92M(+27.3%) | $8.16M(+51.4%) |
Mar 2005 | - | $1.50M(-46.9%) | $5.39M(-43.7%) |
Dec 2004 | $9.58M(-6.1%) | $2.83M(+48.5%) | $9.58M(+8.7%) |
Sep 2004 | - | $1.91M(-323.6%) | $8.81M(-10.6%) |
Jun 2004 | - | -$853.00K(-115.0%) | $9.85M(-25.7%) |
Mar 2004 | - | $5.69M(+175.6%) | $13.26M(+30.0%) |
Dec 2003 | $10.20M(+84.0%) | $2.06M(-30.0%) | $10.20M(+4.3%) |
Sep 2003 | - | $2.95M(+15.5%) | $9.78M(+6.7%) |
Jun 2003 | - | $2.55M(-2.9%) | $9.16M(+22.5%) |
Mar 2003 | - | $2.63M(+60.3%) | $7.48M(+34.9%) |
Dec 2002 | $5.54M(-64.5%) | $1.64M(-29.8%) | $5.54M(-35.2%) |
Sep 2002 | - | $2.34M(+168.9%) | $8.56M(-17.2%) |
Jun 2002 | - | $870.00K(+25.4%) | $10.33M(-24.0%) |
Mar 2002 | - | $694.00K(-85.1%) | $13.60M(-13.0%) |
Dec 2001 | $15.63M(+69.4%) | $4.65M(+13.1%) | $15.63M(+12.5%) |
Sep 2001 | - | $4.12M(-0.4%) | $13.90M(+17.2%) |
Jun 2001 | - | $4.13M(+51.2%) | $11.86M(+16.9%) |
Mar 2001 | - | $2.73M(-6.4%) | $10.14M(+9.8%) |
Dec 2000 | $9.23M(-12.9%) | $2.92M(+40.9%) | $9.23M(+3.6%) |
Sep 2000 | - | $2.07M(-14.1%) | $8.91M(-3.5%) |
Jun 2000 | - | $2.41M(+32.3%) | $9.24M(-4.0%) |
Mar 2000 | - | $1.82M(-29.8%) | $9.62M(-9.2%) |
Dec 1999 | $10.60M(+11.6%) | $2.60M(+8.3%) | $10.60M(-4.5%) |
Sep 1999 | - | $2.40M(-14.3%) | $11.10M(+0.9%) |
Jun 1999 | - | $2.80M(0.0%) | $11.00M(+4.8%) |
Mar 1999 | - | $2.80M(-9.7%) | $10.50M(+9.4%) |
Dec 1998 | $9.50M(+17.3%) | $3.10M(+34.8%) | $9.60M(+6.7%) |
Sep 1998 | - | $2.30M(0.0%) | $9.00M(+5.9%) |
Jun 1998 | - | $2.30M(+21.1%) | $8.50M(+2.4%) |
Mar 1998 | - | $1.90M(-24.0%) | $8.30M(+2.5%) |
Dec 1997 | $8.10M(-84.4%) | $2.50M(+38.9%) | $8.10M(-84.7%) |
Sep 1997 | - | $1.80M(-14.3%) | $52.80M(+0.4%) |
Jun 1997 | - | $2.10M(+23.5%) | $52.60M(+1.0%) |
Mar 1997 | - | $1.70M(-96.4%) | $52.10M(+0.6%) |
Dec 1996 | $51.80M(+859.3%) | $47.20M(+2850.0%) | $51.80M(+763.3%) |
Sep 1996 | - | $1.60M(0.0%) | $6.00M(+5.3%) |
Jun 1996 | - | $1.60M(+14.3%) | $5.70M(+3.6%) |
Mar 1996 | - | $1.40M(0.0%) | $5.50M(+3.8%) |
Dec 1995 | $5.40M(-10.0%) | $1.40M(+7.7%) | $5.30M(-3.6%) |
Sep 1995 | - | $1.30M(-7.1%) | $5.50M(-3.5%) |
Jun 1995 | - | $1.40M(+16.7%) | $5.70M(-1.7%) |
Mar 1995 | - | $1.20M(-25.0%) | $5.80M(-1.7%) |
Dec 1994 | $6.00M(+25.0%) | $1.60M(+6.7%) | $5.90M(-142.1%) |
Sep 1994 | - | $1.50M(0.0%) | -$14.00M(+79.5%) |
Jun 1994 | - | $1.50M(+15.4%) | -$7.80M(+420.0%) |
Mar 1994 | - | $1.30M(-107.1%) | -$1.50M(-130.0%) |
Dec 1993 | $4.80M(-84.2%) | -$18.30M(-337.7%) | $5.00M(-89.8%) |
Sep 1993 | - | $7.70M(-1.3%) | $48.90M(+14.8%) |
Jun 1993 | - | $7.80M(0.0%) | $42.60M(+17.4%) |
Mar 1993 | - | $7.80M(-69.5%) | $36.30M(+20.2%) |
Dec 1992 | $30.30M(+588.6%) | $25.60M(+1728.6%) | $30.20M(+395.1%) |
Sep 1992 | - | $1.40M(-6.7%) | $6.10M(+7.0%) |
Jun 1992 | - | $1.50M(-11.8%) | $5.70M(-28.7%) |
Mar 1992 | - | $1.70M(+13.3%) | $8.00M(+12.7%) |
Dec 1991 | $4.40M(+158.8%) | $1.50M(+50.0%) | $7.10M(+26.8%) |
Sep 1991 | - | $1.00M(-73.7%) | $5.60M(+21.7%) |
Jun 1991 | - | $3.80M(+375.0%) | $4.60M(+475.0%) |
Mar 1991 | - | $800.00K | $800.00K |
Dec 1990 | $1.70M | - | - |
FAQ
- What is Ionis Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual SGA year-on-year change?
- What is Ionis Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly SGA year-on-year change?
- What is Ionis Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM SGA year-on-year change?
What is Ionis Pharmaceuticals annual SGA?
The current annual SGA of IONS is $267.50M
What is the all time high annual SGA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual SGA is $332.20M
What is Ionis Pharmaceuticals annual SGA year-on-year change?
Over the past year, IONS annual SGA has changed by +$34.90M (+15.00%)
What is Ionis Pharmaceuticals quarterly SGA?
The current quarterly SGA of IONS is $76.30M
What is the all time high quarterly SGA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly SGA is $116.70M
What is Ionis Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, IONS quarterly SGA has changed by +$23.70M (+45.06%)
What is Ionis Pharmaceuticals TTM SGA?
The current TTM SGA of IONS is -$8.80B
What is the all time high TTM SGA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM SGA is -$7.20M
What is Ionis Pharmaceuticals TTM SGA year-on-year change?
Over the past year, IONS TTM SGA has changed by -$9.04B (-3769.36%)